Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STATIC study
2018-001382-17Phase 4Unknown
- Sponsor
- Alimentiv Inc.
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Salcrozine in Crohn's disease (2 arms), sponsored by Alimentiv Inc. Primary endpoint: Any Crohn's disease-related complication within 24 months. Status: unknown.
02
Drugs
Salcrozine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2018-001382-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001382-17.